Anticoagulant Therapy for Patients with Coronavirus Disease 2019: Urgent Need for Enhanced Awareness
Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global pandemic. SARS-CoV-2 binds to the angiotensin-converting enzyme 2 receptor, which is abundantly expressed in vascular endothelial cells and damages these cells. Beside...
Guardado en:
Autores principales: | Maki Komiyama, Koji Hasegawa |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7acc58e8d34841e5b13c850b25605391 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Coronavirus Disease 2019: Psychological Stress and Cardiovascular Diseases
por: Maki Komiyama, et al.
Publicado: (2021) -
Smoking Cessation as a Public Health Measure to Limit the Coronavirus Disease 2019 Pandemic
por: Maki Komiyama, et al.
Publicado: (2020) -
Response to the Comment ‘Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
por: Maki Komiyama, et al.
Publicado: (2020) -
Dilated Cardiomyopathy Risk in Patients with Coronavirus Disease 2019: How to Identify and Characterise it Early?
por: Maki Komiyama, et al.
Publicado: (2020) -
Obesity and Cardiovascular Risk After Quitting Smoking: The Latest Evidence
por: Koji Hasegawa, et al.
Publicado: (2019)